TNM staging and T-cell receptor gamma expression in colon adenocarcinoma. Correlation with disease progression?

Tumori

Volumn 94, Issue 3, 2008, Pages 384-388

  Castiglione, Francesca ^a   Taddei, Antonio ^a   Buccoliero, Anna Maria ^a   Garbini, Francesca ^a   Gheri, Chiara Francesca ^a   Freschi, Giancarlo ^a   Bechi, Paolo ^a   Degl'Innocenti, Duccio Rossi ^a   Taddei, Gian Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Colan adenocarcinoma; Immune host response; TCR gamma

Indexed keywords

LYMPHOCYTE RECEPTOR; T CELL RECEPTOR GAMMA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; COLON ADENOCARCINOMA; DNA EXTRACTION; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 48249141466     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400315     Document Type: Article

References (22)

1. International Agency for Research on Cancer (IARC): Pathology and Genetics of Tumours of the Digestive System. In: World Health Organization Classification of Tumors, Kleihues R Sobin LH (Eds), pp 105-106, IARC press, Lyon, 2000.
2. Sheehan KM, 0'Connell F, Q'Grady A, Conroy RM, Leader MB, Byrne MF, Murray FE, Kay EW: The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. Eur J Gastroenterol Hepatol, 16: 619-625, 2004.
3. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res, 58: 3491-3494, 1998.
4. Benhattar J, Delacretaz F, Martin R Chaubert R Costa J: Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms. Diagn Mol Pathol, 4: 108-112, 1995.
5. MulderWM, Stukart MJ, deWindt E, Wagstaff J, Scheper RJ, Bloemena E: Mucin-l-related T cell inflltration in colorectal carcinoma. Cancer Immunol Immunother, 42: 351-356, 1996.
6. Dunn GR Bruce AT, Ikeda H, Old LJ, Schreiber RD: Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol, 3: 991-998, 2002.
7. Marrogi AJ, Munshi A, Merogi AJ, OhadikeY, El-Habashi A, Marrogi OL, Freeman SM: Study of tumor infiltrating lym-phocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer, 74: 492-501, 1997.
8. Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H: Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res, 61: 5132-5136, 2001.
9. Benhattar J, Delacretaz F, Martin R Chaubert P, Costa J: Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasm. Diagn Mol Path, 4: 108-112, 1995.
10. Brenner MB, Strominger JL, Krangel MS: The gamma delta T cell receptor. Adv Immunol, 43: 133-192, 1988.
11. Mombaerts P, Arnoldi J, Russ F, Tonegawa S, Kaufmann SH: Different roles of alpha beta and gamma deltaT cells in immunity against an intracellular bacterial pathogen. Nature, 365: 53-56, 1993.
12. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby R Sutton B, Tigelaar RE, Hayday AC: Regulation of cutaneous malignancy by gamma delta T cells. Science, 294: 605-609, 2001.
13. Ikeguchi M, Oi K, Hirooka Y, Kaibara N: CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma. Eur J Surg Oncol, 30: 53-57, 2004.
14. Vesalainen S, Lipponen R Talja M, Syrjanen K: Histologicalgrade, perineural infiltration, tumour-inflltrating lympho-cytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer, 30A: 1797-1803, 1994.
15. Raspollini MR, Castiglione F, Rossi Degl'innocenti D, Amunni G, Villanucci A, Garbini F, Baroni G, Taddei GL: Tumour-infiltrating gamma/delta T-lymphocytes are corre-lated with a brief disease-free interval in advanced ovarian serous carcinoma. Ann Oncol, 16: 590-596, 2005.
16. Olive C, Nicol D, Falk MC: Characterisation of gamma delta T cells in renal cell carcinoma patients by polymerase chain reaction analysis of T cell receptor transcripts. Cancer Immunol Immunother, 44: 27-34, 1997.
17. Spada FM, Grant ER Peters PJ, Sugita M, Melian A, Leslie DS, Lee HK, van Donselaar E, Hanson DA, Krensky AM, Majdic O, PorcelIi SA, Morita CT, Brenner MB: Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med, 191: 937-948, 2000.
18. Smyth MJ, Trapani JA: Lymphocyte-mediated immunosur-veillance of epithelial cancers? Trends Immunol, 22: 409-411, 2001.
19. McCarthy KP, Sloane JR Kabarowski JH, Matutes E, Wiedemann LM: The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol, 138: 821-828, 1991.
20. Van Ravenswaay Claasen HH, kluin PM, Fleuren GJ: Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest, 67: 166-174, 1992.
21. Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP: Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lym-phocytes in patients with advanced ovarian cancer. Gynecol Obstet Invest, 51: 254261, 2001.
22. Coulie PG, Karanikas V, Colau D, Lurquin C, Landry C, Marchand M, Dorval T, Brichard V, Boon T: A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-speciflc antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci USA, 98: 10290-10295, 2001.